Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000905 |
---|---|
Receipt number | R000001086 |
Scientific Title | Immunotherapy Using HLA-A24-restricted Survivin-derived Peptide Mixed with IFA, IFA and IFN-alpha, IFA and IL-2, or IFA and GM-CSF for Patients with Digestive Cancer and Endocrine Organic Cancer (Phase I clinical study) |
Date of disclosure of the study information | 2007/11/23 |
Last modified on | 2007/11/24 10:08:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2007/11/23 22:27:58 | ||
2 | Update | 2007/11/24 10:08:33 | Recruitment status |